SCHEMBL3149715

SCHEMBL3149715

CCN(CC)c1ccc([N+](=O)[O-])cc1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 1.00
TP53 P04637 1/20 1.00
ALDH1A1 P00352 6/20 0.70
HCAR3 P49019 2/20 0.57
MAPT P10636 6/20 0.54
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.47
GAA P10253 1/20 0.47
CTSV O60911 2/20 0.47
CTSL P07711 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
ALDH3A1 P30838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885646 0.83 ALDH1A1 (1.00) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL11306379 0.78 HTT (0.63) HTTTP53ALDH1A1MAPTKMT2A
SCHEMBL8292564 0.78 TP53 (0.63) HTTTP53ALDH1A1MAPTCYP3A4
SCHEMBL6589180 0.78 HTT (0.63) HTTTP53ALDH1A1MAPTCYP3A4
SCHEMBL1524806 0.78 ALDH3A1 (0.65) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL3895339 0.78 HTT (0.63) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL11577825 0.77 ALDH1A1 (0.73) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL11576314 0.77 ALDH1A1 (0.73) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL6846910 0.77 TP53 (0.62) HTTTP53ALDH1A1HCAR3MAPT
SCHEMBL17368891 0.77 HTT (0.61) HTTTP53ALDH1A1HCAR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109678815-B N-benzyl benzamide derivative and preparation method and pharmaceutical application thereof 中国药科大学 2022-11-29 CN disclosed
EP-1828200-B1 BI- AND TRICYCLIC SUBSTITUTED PHENYL METHANONES AS GLYCINE TRANSPORTER I (GLYT-1) INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE. HOFFMANN LA ROCHE (CH) 2010-02-17 EP disclosed
CN-100586951-C Bi- and tricyclic substituted benzophenones as glycine transporter l(GlyT-1) inhibitors for the treatment of alzheimer's disease. HOFFMANN LA ROCHE 2010-02-03 CN disclosed
US-7375226-B2 Bi- and tricyclic substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2008-05-20 US disclosed
CN-101076532-A Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease. HOFFMANN LA ROCHE (CH) 2007-11-21 CN disclosed
EP-1828200-A1 BI- AND TRICYCLIC SUBSTITUTED PHENYL METHANONES AS GLYCINE TRANSPORTER I (GLYT-1) INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE. F. Hoffmann-Roche AG (CH) 2007-09-05 EP disclosed
WO-2006063709-A1 BI- AND TRICYCLIC SUBSTITUTED PHENYL METHANONES AS GLYCINE TRANSPORTER I (GLYT-1) INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F.HOFFMANN-LA ROCHE AG (CH) 2006-06-22 WO disclosed